Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RXRA | P19793 | 1/20 | 0.33 |
| ▸ | RXRB | P28702 | 1/20 | 0.33 |
| ▸ | PDK2 | Q15119 | 3/20 | 0.32 |
| ▸ | MAOB | P27338 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13507145 | 0.94 | PDK2 (0.34) | PDK2 | |
| SCHEMBL13507974 | 0.91 | LIMK1 (0.34) | RXRARXRBPDK2MAOB | |
| SCHEMBL11922081 | 0.88 | RXRA (0.38) | RXRARXRBPDK2MAOB | |
| SCHEMBL13506803 | 0.87 | RXRA (0.37) | RXRARXRBPDK2MAOB | |
| SCHEMBL11922025 | 0.86 | RXRA (0.42) | RXRARXRBPDK2 | |
| SCHEMBL13507245 | 0.85 | RXRA (0.30) | RXRARXRB | |
| SCHEMBL13508015 | 0.84 | PDK2 (0.33) | PDK2 | |
| SCHEMBL13507575 | 0.83 | MAOB (0.38) | RXRARXRBMAOB | |
| SCHEMBL24647431 | 0.82 | PDK2 (0.42) | PDK2 | |
| SCHEMBL19849872 | 0.82 | PDK2 (0.42) | PDK2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100032658-A1 | Novel organic electroluminescent compounds and organic electroluminescent device using the same | GRACEL DISPLAY INC. (KR) | 2010-02-11 | — | — | US | disclosed |
| US-20100032658-A1 | Novel organic electroluminescent compounds and organic electroluminescent device using the same | GRACEL DISPLAY INC. (KR) | 2010-02-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100032658-A1 | Novel organic electroluminescent compounds and organic electroluminescent device using the same | OCIAD1, OCIAD2, ORMDL3 | RXRA 3214/4885RXRB 3507/4885PDK2 1690/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.